GeneMatrix Inc (109820) — Capital Reinvestment Ratio

Latest as of September 2025: 0.05x

GeneMatrix Inc (109820) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩500.19 Million) in capital expenditures (₩23.65 Million). Check GeneMatrix Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

₩500.19 Million
KRW

Capital Expenditures

₩23.65 Million
KRW

Data as of

Sep 2025
Most recent filing

GeneMatrix Inc Capital Reinvestment Ratio (2020–2021)

This chart tracks GeneMatrix Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see GeneMatrix Inc cash flow conversion.

Annual Capital Reinvestment Ratio for GeneMatrix Inc (2020–2021)

Year-by-year Capital Reinvestment Ratio for GeneMatrix Inc from 2020 to 2021. See 109820 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2021 0.08x ₩3.37 Billion ₩258.22 Million ▼ -5.8%
2020 0.08x ₩4.51 Billion ₩366.56 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow